Adaptive Announces Pricing of Public Offering of Common Stock

NEXT STORY
Applied Therapeutics, Inc. Announces Upsizing and Pricing of Public Offering of 2,741,489 Shares of Common Stock
PREV STORY
UPDATED: Austin Regional Clinic Recruiting Families for Clinical Trial Testing Mobile Device to Aid Autism Diagnosis in Young Children
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Aucta Receives its First Product Approval and Launches Vigabatrin for Oral Solution Under the Brand Name Vigadrone™

NEW BRUNSWICK, N.J., July 16, 2018 (GLOBE NEWSWIRE) -- Aucta Pharmaceuticals, Inc. (Aucta) announced ...

author_avatar
NASDAQ Market News

Chembio Diagnostics Reports Second Quarter 2018 Financial Results

MEDFORD, N.Y., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a ...

author_avatar
NASDAQ Market News

AzurRx CEO Provides Shareholders With a “State of the Union” Communication

BROOKLYN, N.Y., Dec. 01, 2016 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX) (“AzurRx” or ...

author_avatar
NASDAQ Market News